Autoimmune And Rheumatic Diseases
Hooked on Rheum with Carrie Beach, BSN, RN-BC
My path to rheumatology was certainly not one that I had planned on, or even dreamed about, during nursing school.
‘A ton of confusion’: Rheumatology providers, patients prepare for end of COVID emergency
May 11 will mark the end of the 3-year COVID-19 national public health emergency, as announced earlier this year by President Joe Biden and HHS.
Outpatient COVID therapy linked to 88% lower odds of severe outcomes in AIRD patients
Patients with autoimmune rheumatic disease who receive outpatient therapy are 88% less likely to develop severe COVID-19 outcomes vs. with those who do not undergo outpatient therapy, according to data published in The Lancet Rheumatology.
Hooked on Rheum with George Muñoz, MD
As a fourth-year medical student doing an elective rotation in rheumatology, I was initially impressed by my first mentor, Dr. Harry Spiera, section chief and clinician extraordinaire at Mount Sinai Hospital in New York City.
Mindfulness helpful in improving physical, mental inflammatory outcomes
SCOTTSDALE, Ariz. — Mindfulness exercises may help improve both physical and mental outcomes in patients with inflammatory diseases, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
Few rheumatologists say economic benefits of biosimilars sufficient to warrant switching
Although most rheumatologists report they are comfortable with the idea of prescribing biosimilars, only approximately 18% think the economic benefits warrant switching their patients to one, according to a Cardinal Health survey.
COVID-19 pandemic ‘still with us’ for patients with autoimmune, inflammatory diseases
SCOTTSDALE, Ariz. — Although omicron variants appear generally less severe and more manageable than previous SARS-CoV-2 strains, patients with rheumatologic conditions should remain vigilant, according to a presenter.
'Now everyone's an immunologist': How COVID-19 helps improve understanding of immunology
SCOTTSDALE, Ariz — The study of COVID-19 may in turn improve the understanding of immunology by demonstrating that the immune system is “highly alive,” said a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.
‘Unity among nations’: The rise and promise of global collaborations in rheumatology
An ironic twist of the COVID-19 pandemic was that as most of the world huddled indoors, opportunities for health care professionals to communicate and collaborate across great distances flourished, particularly in rheumatology.
Alzheimer’s as an autoimmune disease: ‘We will need competence in the area of immunology’
What if Alzheimer’s disease, a neurological disorder that has confounded researchers since its identification in 1907, were not a brain disorder at all? What if it were instead an autoimmune disease that attacks the brain?